How Ageing Reshapes the Body’s Defense Against Infection

Ageing profoundly alters how the human body detects, responds to, and recovers from infection, turning once-manageable pathogens into significant threats for many older adults. As the immune system changes over time, infections become more frequent, more severe, and more likely to cause complications, with wide-ranging implications for individual health, health-care systems, and economies worldwide.

The Immune System Across the Lifespan

From infancy through early adulthood, the immune system develops and refines its ability to recognize and neutralize a vast range of microbes. Over decades, repeated exposure to viruses, bacteria, and vaccines builds a repertoire of immune memory that helps the body respond quickly to familiar threats.

With advancing age, however, this finely tuned system undergoes structural and functional changes often grouped under the term “immunosenescence.” This process involves both the fast-acting innate immune system and the highly specific adaptive immune system, gradually eroding the body’s capacity to mount rapid and robust responses to new infections.

Decline of Innate Defenses in Older Adults

The innate immune system acts as the first line of defense, relying on physical barriers, chemical signals, and cells that rapidly detect danger. In older individuals, several aspects of this front-line defense become less efficient, contributing to delayed recognition and clearance of invading microbes.

Key age-related changes include:

• Reduced function of sentinel cells: Cells such as macrophages and dendritic cells show impaired ability to sense pathogens and to migrate to sites of infection, slowing the initial alarm phase of the immune response.
• Altered inflammatory signaling: The coordination of pro- and anti-inflammatory signals becomes dysregulated, leading to a slower, less targeted reaction or, in some cases, an excessive and poorly controlled inflammatory response.

These shifts mean that common respiratory or urinary tract infections can spread more easily and progress more rapidly in older adults, increasing the likelihood of hospitalization and severe outcomes.

Ageing and the Adaptive Immune Response

The adaptive immune system, which includes T cells and B cells, provides targeted responses and long-lasting immune memory. Ageing brings pronounced changes to this arm of immunity, affecting both the quantity and quality of immune cells and the speed with which they respond.

Several factors contribute to this decline:

• Shrinking thymus and T cell diversity: The thymus, where T cells mature, gradually shrinks from early adulthood, limiting the production of new T cells capable of recognizing novel pathogens. This leaves older adults more reliant on existing memory cells and less able to respond to previously unseen microbes.
• Weakened B cell function: B cells in older individuals often produce fewer and less effective antibodies, which can reduce the strength and precision of responses during infection and after vaccination.

The combined effect is a slower, less flexible adaptive response that struggles to keep pace with rapidly replicating pathogens, particularly emerging viruses or highly variable strains.

Inflammaging: Chronic Low-Grade Inflammation

One of the most notable immunological features of ageing is “inflammaging,” a state of chronic, low-grade inflammation that persists even in the absence of active infection. This background inflammation is thought to arise from lifelong exposure to environmental stressors, cellular damage, and persistent infections.

While a controlled inflammatory response is essential for fighting infection, constant low-level activation can be harmful. Inflammaging can:

• Exhaust immune cells and blunt their responsiveness when a genuine threat appears.
• Contribute to tissue damage and worsen chronic diseases such as cardiovascular disease, diabetes, and neurodegeneration, which in turn make infection outcomes more severe.

When an older person encounters a new pathogen, this pre-existing inflammatory burden can interfere with the ability to generate a sharp, targeted immune response, increasing the risk of complications such as sepsis, organ failure, or prolonged recovery.

Changing Patterns of Infection in Older Populations

The biological changes of ageing translate directly into altered patterns of infection at the population level. Older adults are more likely to experience:

• Higher incidence of certain infections: Respiratory infections like influenza and pneumonia, as well as urinary tract and skin infections, occur more frequently and carry greater risks.
• More severe disease courses: Conditions that younger adults often manage at home can lead to hospitalization, intensive care, or long-term disability in older individuals.

These vulnerabilities are further heightened by common age-associated conditions such as frailty, malnutrition, and chronic diseases, which can limit mobility, reduce lung capacity, or impair organ function, all of which complicate the body’s response to infection.

Vaccines and Reduced Immune Memory in Ageing

Vaccination remains one of the most important tools for preventing infection in older adults, yet vaccines often work less effectively in this group due to immunosenescence. Diminished immune memory and slower activation of protective mechanisms can result in weaker responses to standard vaccine doses.

To address this challenge, health authorities and researchers have developed strategies such as:

• High-dose and adjuvanted vaccines: Enhanced formulations designed to stimulate a stronger immune response in older recipients for diseases like influenza.
• Booster and seasonal campaigns: More frequent boosters to maintain protective antibody levels against respiratory viruses and other pathogens that pose heightened risk in later life.

Even when vaccine-induced protection is not complete, these interventions can substantially reduce the chances of severe illness, hospital admission, and death among older populations.

Historical Perspective on Ageing and Infection

Historically, infectious diseases have been a major cause of death across all age groups, but improvements in sanitation, antibiotics, and vaccination shifted much of the burden toward younger individuals in the early and mid‑20th century. Over time, as life expectancy rose and chronic diseases became more prominent, the vulnerability of older adults to infection gained increasing attention.

Events such as seasonal influenza epidemics and global outbreaks of respiratory viruses have repeatedly demonstrated that older adults face disproportionate risks, with higher mortality rates and longer recovery periods. These patterns have driven ongoing research into age-related immune changes and prompted public health authorities to place greater emphasis on targeted vaccination and infection prevention measures for older populations.

Economic Impact of Infection in Ageing Societies

As societies age, the interplay between immunosenescence and infection has significant economic consequences. Higher infection rates among older adults translate into increased hospital admissions, longer stays, and greater demand for intensive care, driving up health-care costs.

Beyond direct medical expenses, there are broader economic effects:

• Increased need for long-term care: Severe infections can accelerate functional decline, leading to greater reliance on home care services or residential facilities.
• Reduced productivity of caregivers: Family members may need to reduce working hours or leave the workforce to care for older relatives recovering from infection, affecting household income and national productivity.

In countries with rapidly ageing populations, these pressures can strain public health budgets and social support systems, prompting calls for more preventive strategies and early interventions to limit infection-related complications.

Regional Comparisons in an Ageing World

The impact of ageing on infection management varies by region, reflecting differences in demographics, health-care infrastructure, vaccination programs, and social support for older adults. High-income regions with well-developed health systems often have broad vaccination coverage, access to advanced treatments, and established protocols for infection control in hospitals and long-term care facilities.

In many low- and middle-income regions, however, rising numbers of older adults coincide with limited access to vaccines, diagnostics, and specialized care. In such settings, preventable infections can carry higher fatality rates and cause more severe long-term disability among older people.

Even within the same region, disparities in income, housing, and access to primary care influence how effectively older individuals can avoid or manage infections. Congregate living arrangements, limited mobility, and social isolation can all affect exposure risk and the timeliness of medical attention.

Public Health Strategies to Protect Older Adults

Understanding how ageing changes the immune system is central to designing effective strategies to protect older adults from infections. Public health approaches increasingly combine biomedical interventions with social and environmental measures tailored to the needs of ageing populations.

Key elements include:

• Targeted vaccination programs: Prioritizing older adults for vaccines against respiratory viruses, pneumococcal disease, and other major infectious threats, and adapting formulations to address reduced immune responsiveness.
• Infection prevention in care settings: Strengthening hygiene practices, surveillance, and rapid response protocols in hospitals and long-term care facilities to prevent outbreaks among vulnerable residents.
• Support for healthy ageing: Encouraging physical activity, balanced nutrition, and management of chronic conditions, which can bolster overall resilience and help the immune system function more effectively despite age-related changes.

These measures work best when coordinated across primary care, community services, and specialized geriatric and infectious disease teams, ensuring that older individuals receive timely, appropriate care when infections arise.

Looking Ahead: Research and Innovation

Scientific interest in the relationship between ageing and infection continues to grow, with researchers using both human studies and animal models to examine how aged immune cells differ from their younger counterparts. Altered signaling pathways, shifts in cellular metabolism, and the persistent background of inflammaging are central themes in this work.

Future developments may include:

• More precise vaccines: Tailored to the specific immune profiles of older adults, with refined adjuvants and delivery methods designed to overcome immunosenescence.
• Therapies targeting inflammaging: Interventions that reduce chronic low-grade inflammation without compromising essential immune defenses, potentially improving responses to both infection and vaccination.

As populations worldwide continue to age, the question of how ageing influences the way bodies handle infection is likely to remain at the forefront of medical and public health research. Understanding and addressing the complex interplay of immunosenescence, inflammaging, and environmental factors will be critical for safeguarding the health and independence of older adults in the decades ahead.